Skip to content
Monday, May 23, 2022
Latest:
  • TikTok Benadryl Challenge
  • The full list of hand sanitizers to avoid
  • FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
  • Is acetaminophen a carcinogen?
  • Belviq and risk of cancer linked

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

  • Home
  • FDA Recalls
  • Drug Recalls
  • Current Lawsuits
  • Contact

FDA Advisory

FDA Advisory

FDA Advisory 

Risk of Tramadol in children aged 17 years and younger

September 21, 2015September 21, 2015

FDA is evaluating risks of using Tramadol in children aged 17 and younger Tramadol is not FDA-approved for use in

Read more
FDA Advisory Onglyza 

Onglyza Linked to Pancreatic Cancer

September 10, 2015September 10, 2015 Onglyza, Pancreatic Cancer

The popular diabetes type-2 treatment Onglyza (saxagliptin) was jointly developed by AstraZeneca and Bristol-Myers Squibb. Onglyza is a popular medication,

Read more
FDA Advisory 

Opioid Increases risk of Neonatal Abstinence Syndrome

April 13, 2015 NAS, Neonatal Abstinence Syndrome

Opioid pain use during pregnancy increases risk Of NSA (Neonatal Abstinence Syndrome) Researchers at Vanderbilt University Medical Center studied neonatal

Read more
Current Lawsuits FDA Advisory Zofran 

Zofran Lawsuit

March 4, 2015 Lawsuit, zofran

Zofran Lawsuit Update Several medical studies have highlighted the risk of Zofran side effects, including cleft palate, cleft lip and

Read more
Current Lawsuits Drug Recalls FDA Advisory Zofran 

Zofran Birth Defect Warning

February 21, 2015 birth defect, cleft lip, cleft palate, zofran

Attention Women. Zofran has been linked to serious birth defects. FDA Warns Against Zofran Use in Pregnancy The FDA has

Read more
FDA Advisory 

Birth control pills linked to breast cancer

August 2, 2014

Study links certain birth control pills to higher Breast Cancer Risk among Women 20 to 49 Years of Age This

Read more
FDA Advisory Paxil 

GlaxoSmithKline settles for $105 million

June 4, 2014June 4, 2014 0 Comments

GlaxoSmithKline settles for $105 million over label dispute with 45 states. GlaxoSmithKline has agreed to pay $105 million to 45

Read more
FDA Advisory 

ADHD Drugs may cause painful Erections

December 17, 2013 0 Comments Concerta, Daytrana, Focalin/Focalin XR, Metadate CD/Metadate ER, Methylin/Methylin ER, methylphenidate, priapism, Quillivant XR, Ritalin/Ritalin LA/Ritalin SR

Methylphenidate products are central nervous system (CNS) stimulants used to treat attention deficit hyperactivity disorder (ADHD). FDA is warning that

Read more
FDA Advisory 

MS drug Gilenya tied to brain infection

August 29, 2013August 29, 2013 0 Comments fingolimod, Gilenya

FDA is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare

Read more
FDA Advisory 

FDA warns that Ortiga contains diclofenac

August 22, 2013 0 Comments diclofenac, Ortiga

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Ortiga, an unapproved product promoted for

Read more
  • ← Previous
  • Next →

Recent Posts

  • TikTok Benadryl Challenge
  • The full list of hand sanitizers to avoid
  • FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
  • Is acetaminophen a carcinogen?
  • Belviq and risk of cancer linked

Categories

Useful Links

  • DailyMed – marketed drugs
  • FDA Drug Recalls
  • MedlinePlus Drugs Information
  • Pillbox – Pill identification
  • Terms of use
  • About
  • Contact
Copyright © 2022 Faulty Drugs. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.